GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 63 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $587,292 | -11.8% | 341,449 | 0.0% | 0.00% | – |
| Q2 2023 | $665,825 | -80.8% | 341,449 | -55.1% | 0.00% | -100.0% |
| Q1 2022 | $3,470,000 | -69.4% | 760,986 | -22.3% | 0.00% | -66.7% |
| Q4 2021 | $11,341,000 | +31.4% | 979,343 | +30.5% | 0.00% | 0.0% |
| Q3 2021 | $8,631,000 | +134.7% | 750,529 | +86.3% | 0.00% | +200.0% |
| Q2 2021 | $3,678,000 | +192.1% | 402,796 | +201.7% | 0.00% | – |
| Q1 2021 | $1,259,000 | +103.1% | 133,526 | -15.2% | 0.00% | – |
| Q4 2020 | $620,000 | +46.6% | 157,370 | -1.4% | 0.00% | – |
| Q3 2020 | $423,000 | -53.8% | 159,610 | +15.6% | 0.00% | – |
| Q2 2020 | $916,000 | +25.3% | 138,015 | +9.9% | 0.00% | – |
| Q1 2020 | $731,000 | -30.1% | 125,568 | +7.8% | 0.00% | – |
| Q4 2019 | $1,046,000 | +3.1% | 116,529 | -0.9% | 0.00% | – |
| Q3 2019 | $1,015,000 | +36.2% | 117,584 | +75.8% | 0.00% | – |
| Q2 2019 | $745,000 | – | 66,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |